ReviewFrontiers in psychiatry2019

The Use of Cognitive Screening in Pharmacotherapy Trials for Cognitive Impairment Associated With Schizophrenia.

Jack Cotter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.